Research has revolutionised the lives of people with asthma


Section Menu

Connect with us

We're here to help.

Contact us or call 1800 ASTHMA (1800 278 462)

  • Follow us on Twitter
  • Like us on Facebook
  • Subscribe to YouTube

CMAX Clinical Research is looking for people with mild asthma to participate in a clinical drug study

CMAX Clinical Research is trialling an inhaled investigational medication for people with asthma whose symptoms cannot be controlled by current therapies.

This trial has received ethics approval from the Bellberry Human Research Ethics Committee. The HREC Reference number is: 2018-05-354

To be eligible, participants* must be aged 18 to 55 and have a documents diagnosis of mild asthma. Participants must also have a Body Mass Index of 18 to 35.

*Females must be of non-childbearing potential: post-menopausal or surgically sterile

The study involves staying at CMAX for 12 nights and attending 2 follow up visits. The trial is located in Adelaide

Eligible participants will be paid for their time.

To register your interest or receive more information please phone CMAX on 1800 150 433.

National Supporters

Principal Partner:





Program Partners:


Health logo 







Research Partners:




Campaign Partner:  ooh-unmissable


logo tarkett blue



State Supporters

nsw-health-logo  Qld_Gov   
Fay Fuller Foundation Logo
 SA_partners_electranet  SA_partners_sapower  



Please select your location


Western Australia Northern Territory Queensland Queensland Australian Capital Territory Australia Capital Territory New South Wales South Australia Victoria Tasmania

So we can provide you with the most correct information, please select your location below:

This website is a collaboration between Asthma Australia and Asthma Foundations ACT, NSW, NT, QLD, VIC, WA, TAS and SA